As reported in Physics World (October 2008) Tessella is providing software services to the next-generation ITER fusion reactor being built in France.  Richard Layne, Tessellas’ Fusion Project Manager explains how the company is building on its extensive experience supporting fusion research at the Joint European Torus.

Webinar: Perspective on the future of drug development, October 16th 2008 The Tessella and Pharmaceutical Business Review free webinar Perspective on the future of drug development. Speakers included Tessella’s Tom Parke and Grant Stephen, Prof Don Berry of Berry Consultants, and Nick Bennett the lead pharma analyst at Datamonitor.

Adaptive Clinical Trial Designs, October 23-24th 2008, Washington DC Parvin Fardipour (Director of Implementation, Adaptive Trial Design, at Wyeth) will be presenting ‘Adaptive Dose-Ranging Studies in Learn’. Parvin will describe her experience in planning, implementing and executing adaptive dose-ranging studies in clinical drug development. The objective of the session is to give a first-hand report [...]

The Tessella and AIIM free webinar Digital Preservation: challenges and benefits, held on October 15th 2008, was a huge success with over 300 attendees world-wide. The speakers, Tessella’s Mark Evans and Prof Greg Hunter of Long Island University (and Senior Consultant to History Associates, Inc.) discussed the need to take steps now to address digital preservation. Lessons learned during [...]

Tessella’s Mark Evans and Prof Greg Hunter of Long Island University (and Senior Consultant to History Associates, Inc.) discuss the need to take steps now to address digital preservation and lessons learned during work on the US National Archives and Records Administration’s Electronic Records Archive (ERA) program.

The Tessella and Pharmaceutical Business Review free webinar Perspective on the future of drug development. Speakers included Tessella’s Tom Parke and Grant Stephen, Prof Don Berry of Berry Consultants, and Nick Bennett the lead pharma analyst at Datamonitor.

As reported in Clinical Discovery magazine (October 2008), Tom Parke, Head of Clinical Trials Solutions at Tessella, discusses the industry’s adoption of adaptive clinical trials and highlights where the advances, and operational difficulties, lie.

Tessella, the technology and consulting services company selected by R&D, science and engineering leaders for business-critical assignments, is continuing to expand.  Back in 2005, Tessella Inc acquired other offices in Washington DC to support the $308 million, six year contract to build the electronic Records Archives System for the National Archives and Records Administration (NARA).  [...]

Who has not been frustrated when using their favorite search engine only to discover that many of the results are simply not relevant? This is the challenge that Brandy King and Kathy Reinold explore in the book “Finding the Concept, Not just the Word”. This cross disciplinary team, Brandy is a librarian and Kathy is [...]